Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating oral ruxolitinib (INCB018424) in patients with androgen independent metastatic prostate cancer was termi…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a short-course hypofractionated radiotherapy regimen for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating Strontium-89 with or without Cisplatin for palliation of bone pain in hormone-refractory prostate cancer with bon…
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel [Phase 1]
Phase 1 study evaluating a vaccine therapy using recombinant soluble PSMA with the Alhydrogel adjuvant in prostate cancer patients; the tria…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
This completed clinical trial evaluated the efficacy and safety of Lucrin Depot (goserelin acetate) in men with advanced prostate cancer and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Imaging for Significant Prostate Cancer Risk Evaluation [NA]
Clinical trial update describing imaging for significant risk evaluation in prostate cancer, sponsored by University College London Hospital…
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer [Phase 2]
A Phase 2 study evaluating bafetinib (INNO-406) in patients with hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: ARTS - AVODART After Radical Therapy For Prostate Cancer Study [Phase 2]
Phase 2 trial evaluating dutasteride (AVODART) after radical therapy for prostate cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation
The clinical trial update reports that the study evaluating biological imaging to optimise CTV and GTV contouring for IMRT dose escalation i…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Sutent Maintenance After Response to Taxotere [Phase 2]
Phase 2 trial update of maintenance sunitinib (Sutent) after response to docetaxel (Taxotere) in hormone-refractory prostate cancer.
-
CLINICAL_TRIALS research · 2011-12-07Clinical Trial Update: An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer
This is a clinical trial update evaluating polymer-based fiducials for imaging in patients undergoing treatment for prostate cancer; the tri…
-
CLINICAL_TRIALS research · 2011-12-02Clinical Trial Update: The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
This clinical trial update investigates whether PSA density velocity while taking dutasteride can predict prostate cancer incidence and the …
-
CLINICAL_TRIALS withdrawal · 2011-12-02Clinical Trial Update: Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines [Phase 1, Phase 2]
A Phase 1/2 trial evaluating hTERT mRNA-transfected dendritic cell vaccines for metastatic prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-11-28Clinical Trial Update: Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer [Phase 2]
This ClinicalTrials.gov update reports the termination of a Phase 2 feasibility study evaluating a dose increase using a Curietherapy boost …
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy [NA]
The trial comparing lidocaine to placebo for pain control during transrectal ultrasound-guided prostate biopsy has completed.
-
CLINICAL_TRIALS research · 2011-11-08Clinical Trial Update: Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance
This trial update reports on research examining hypoxia in prostate cancer. It focuses on potential diagnostic markers and the prognostic si…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers [Phase 2]
A Phase 2 trial of the carboplatin–etoposide combination for hormone-resistant prostate cancer has completed.
-
FDA approval · 2011-11-02FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Bicalutamide from Accord Healthcare Inc., updating its labeling.
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer [NA]
This completed clinical trial evaluated guided imagery and progressive muscle relaxation to improve psychological well-being and quality of …
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Assessment of the Functional Significance of Accessory Pudendal Arteries [NA]
The clinical trial assessing the functional significance of accessory pudendal arteries has completed, with the study status listed as compl…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 clinical trial update for SGN-15 in hormone-refractory prostate cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy [Phase 2]
Phase 2 trial evaluating the combination of trastuzumab and docetaxel in metastatic prostate cancer refractory to hormone therapy has been c…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Study Using CP-461 to Treat Advanced Prostate Cancer [Phase 2]
A Phase 2 trial evaluating CP-461 for advanced prostate cancer has completed.
-
CLINICAL_TRIALS research · 2011-10-17Clinical Trial Update: MRI/MRSI in Risk Assessment of Prostate Cancer Patients [NA]
This document summarizes a completed clinical trial evaluating MRI and MR spectroscopy imaging for risk assessment in prostate cancer patien…
-
FDA approval · 2011-10-14FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)
The FDA approved a supplemental application for bicalutamide submitted by Viona Pharmaceuticals Inc., updating the drug's labeling.